A case of pelvic squamous cell carcinoma of unknown primary origin that responded well to radiotherapy and nivolumab

• 出版年: Radiology Case Reports
• 主要な著者: Hiroaki Koge, MD, Ayako Hino, MD, PhD, Akira Kakiuchi, MD, Yayoi Yamamoto, MD, PhD, Akira Kanbe, MD, Daichi Kojima, MD, Ayumi Horikawa, MD, PhD, Tsunehiro Doiuchi, MD, Hiroaki Kurihara, MD, PhD
• フォーマット: 論文
• 言語: 英語
• 出版事項: Elsevier 2024-05-01
• 主題: Unknown primary origin; Pelvis, Osteolytic; Squamous cell carcinoma; Radiotherapy; Nivolumab
• オンライン･アクセス: http://www.sciencedirect.com/science/article/pii/S1930043324000591
• ISSN: 1930-0433

Squamous cell carcinoma of unknown primary origin in the pelvis is rare. We report a case of a 64-year-old woman with a large osteolytic squamous cell carcinoma of unknown primary origin in the pelvis that presented with p16 expression. The patient presented with leg pain and swelling and was admitted to our hospital. Computed tomography scans of the pelvis revealed a large osteolytic tumor. A computed tomography-guided needle biopsy was performed, and pathological examination revealed neoplastic cells with metastatic squamous cell carcinoma presenting with p16 expression. Despite a whole-body examination, tumor origin remained undetected. The patient was treated for this metastatic squamous cell carcinoma of unknown primary using palliative radiotherapy for hip pain and nivolumab. Remarkable reduction in the tumor marker levels and tumor size were obtained after therapy. Finally, partial remission and progression-free survival for more than 7 months were achieved. In conclusion, we experienced a rare case with a large p16-positive squamous cell carcinoma of unknown primary in pelvis, which responded well to radiotherapy and nivolumab.